| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |